DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on July 21, 2004; DOI: 10.1124/dmd.104.000273


0090-9556/04/3210-1162-1169$20.00
DMD 32:1162-1169, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.104.000273v1
32/10/1162    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, L.-Q.
Right arrow Articles by James, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.-Q.
Right arrow Articles by James, M. O.

TRICLOSAN AS A SUBSTRATE AND INHIBITOR OF 3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE-SULFOTRANSFERASE AND UDP-GLUCURONOSYL TRANSFERASE IN HUMAN LIVER FRACTIONS

Li-Quan Wang, Charles N. Falany, and Margaret O. James

Department of Medicinal Chemistry, University of Florida, Gainesville, Florida (L.-Q.W., M.O.J.); and Department of Pharmacology and Toxicology, University of Alabama, Birmingham, Alabama (C.N.F.)

Triclosan is a broad spectrum antibacterial agent used in many household products. Due to its structural similarity to polychlorobiphenylols, which are potent inhibitors of the sulfonation and glucuronidation of 3-hydroxy-benzo[a]pyrene, it was hypothesized that triclosan would inhibit these phase II enzymes. This study was designed to assess the interactions of triclosan as a substrate and inhibitor of 3'-phosphoadenosine 5'-phosphosulfate-sulfotransferases and UDP-glucuronosyltransferases in human liver cytosol and microsomes. Triclosan was sulfonated and glucuronidated in human liver. The apparent Km and Vmax values for triclosan sulfonation were 8.5 µM and 0.096 nmol/min/mg protein, whereas Km and Vmax values for glucuronidation were 107 µM and 0.739 nmol/min/mg protein. Triclosan inhibited the hepatic cytosolic sulfonation of 3-hydroxybenzo(a)pyrene (3-OH-BaP), bisphenol A, p-nitrophenol, and acetaminophen with IC50 concentrations of 2.87, 2.96, 6.45, and 17.8 µM, respectively. Studies of 3-OH-BaP sulfonation by expressed human SULT1A1*1, SULT1A1*2, SULT1B1, and SULT1E1 showed that triclosan inhibited the activities of each of these purified enzymes with IC50 concentrations between 2.09 and 7.5 µM. Triclosan was generally a less potent inhibitor of microsomal glucuronidation. IC50 concentrations for triclosan with 3-OH-BaP, acetaminophen, and bisphenol A as substrates were 4.55, 297, and >200 µM, respectively. Morphine glucuronidation was not inhibited by 50 µM triclosan. The kinetics of 3-OH-BaP sulfonation and glucuronidation were examined in the presence of varying concentrations of triclosan: the inhibition of sulfonation was noncompetitive, whereas that of glucuronidation was competitive. These findings reveal that the commonly used bactericide triclosan is a selective inhibitor of the glucuronidation and sulfonation of phenolic xenobiotics.


Address correspondence to: Dr. Margaret O. James, Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville FL 32610-0485. E-mail: mojames{at}ufl.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
L. P. Volak, S. Ghirmai, J. R. Cashman, and M. H. Court
Curcuminoids Inhibit Multiple Human Cytochromes P450, UDP-Glucuronosyltransferase, and Sulfotransferase Enzymes, whereas Piperine Is a Relatively Selective CYP3A4 Inhibitor
Drug Metab. Dispos., August 1, 2008; 36(8): 1594 - 1605.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. C. Sacco, H.-J. Lehmler, L. W. Robertson, W. Li, and M. O. James
Glucuronidation of Polychlorinated Biphenylols and UDP-Glucuronic Acid Concentrations in Channel Catfish Liver and Intestine
Drug Metab. Dispos., April 1, 2008; 36(4): 623 - 630.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Freundlich, F. Wang, H.-C. Tsai, M. Kuo, H.-M. Shieh, J. W. Anderson, L. J. Nkrumah, J.-C. Valderramos, M. Yu, T. R. S. Kumar, et al.
X-ray Structural Analysis of Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase as a Pathway toward the Optimization of Triclosan Antimalarial Efficacy
J. Biol. Chem., August 31, 2007; 282(35): 25436 - 25444.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. M. Smith, R. A. Graham, W. L. Krol, I. S. Silver, M. Negishi, H. Wang, and E. L. Lecluyse
Differential UGT1A1 Induction by Chrysin in Primary Human Hepatocytes and HepG2 Cells
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1256 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. C. Sacco and M. O. James
SULFONATION OF ENVIRONMENTAL CHEMICALS AND THEIR METABOLITES IN THE POLAR BEAR (Ursus maritimus)
Drug Metab. Dispos., September 1, 2005; 33(9): 1341 - 1348.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.